Trial Profile
Clinical Trials Insight: 700059914
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs XP 21279 (Primary) ; Carbidopa; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors XenoPort
- 30 Sep 2010 New trial record